Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Accumulated Expenses: 2019-2025

Historic Other Accumulated Expenses for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $2.0 million.

  • Biodesix's Other Accumulated Expenses fell 23.65% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 23.65%. This contributed to the annual value of $2.4 million for FY2024, which is 17.31% down from last year.
  • Biodesix's Other Accumulated Expenses amounted to $2.0 million in Q3 2025, which was down 13.38% from $2.3 million recorded in Q2 2025.
  • Biodesix's Other Accumulated Expenses' 5-year high stood at $4.6 million during Q1 2021, with a 5-year trough of $1.5 million in Q1 2023.
  • Over the past 3 years, Biodesix's median Other Accumulated Expenses value was $2.4 million (recorded in 2024), while the average stood at $2.4 million.
  • Per our database at Business Quant, Biodesix's Other Accumulated Expenses slumped by 45.09% in 2023 and then spiked by 134.44% in 2024.
  • Over the past 5 years, Biodesix's Other Accumulated Expenses (Quarterly) stood at $2.8 million in 2021, then declined by 16.31% to $2.3 million in 2022, then climbed by 24.06% to $2.9 million in 2023, then dropped by 17.31% to $2.4 million in 2024, then dropped by 23.65% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.3 million for Q2 2025, and $2.2 million during Q1 2025.